J&J Recalls Children's Benadryl, Motrin
NEW BRUNSWICK, N.J. (TheStreet) -- Johnson & Johnson (JNJ) plans to recall Children's Benadryl allergy tablets and junior-strength Motrin caplets because of manufacturing problems.
J&J's McNeil Consumer Healthcare division was recalling the products because of "insufficiencies in the development of the manufacturing process," the company said.
On its Web site, McNeil said the recall was at the wholesale and retail level. "No action is required by consumers or healthcare providers and consumers can continue to use the product," McNeil said.
Bloomberg reports 4 million packages of Children's Benadryl allergy tablets and about 800,000 bottles of junior-strength Motrin caplets would be recalled.
A notice dated Nov. 15 was posted on the McNeil Web site, but no press release was issued. J&J has issued a number of recalls this year, the latest on Oct. 18, when McNeil announced the recall of one product lot of 50-count bottles of Tylenol eight-hour caplets in the U.S. and Puerto Rico because of a strange musty or moldy odor. -- Written by Joseph Woelfel>To contact the writer of this article, click here: Joseph Woelfel >To submit a news tip, send an email to: tips@thestreet.com.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
